These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34698667)

  • 1. The emerging role of cardiac contractility modulation in heart failure treatment.
    Chinyere IR; Balakrishnan M; Hutchinson MD
    Curr Opin Cardiol; 2022 Jan; 37(1):30-35. PubMed ID: 34698667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
    Wiegn P; Chan R; Jost C; Saville BR; Parise H; Prutchi D; Carson PE; Stagg A; Goldsmith RL; Burkhoff D
    Circ Heart Fail; 2020 Apr; 13(4):e006512. PubMed ID: 32264716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
    Abraham WT; Kuck KH; Goldsmith RL; Lindenfeld J; Reddy VY; Carson PE; Mann DL; Saville B; Parise H; Chan R; Wiegn P; Hastings JL; Kaplan AJ; Edelmann F; Luthje L; Kahwash R; Tomassoni GF; Gutterman DD; Stagg A; Burkhoff D; Hasenfuß G
    JACC Heart Fail; 2018 Oct; 6(10):874-883. PubMed ID: 29754812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction.
    Talha KM; Anker SD; Burkhoff D; Filippatos G; Lam CSP; Stone GW; Wazni O; Butler J
    J Card Fail; 2022 Dec; 28(12):1717-1726. PubMed ID: 36122819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads.
    Röger S; Said S; Kloppe A; Lawo T; Emig U; Rousso B; Gutterman D; Borggrefe M; Kuschyk J
    J Cardiol; 2017 Jan; 69(1):326-332. PubMed ID: 27590412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design.
    Abraham WT; Lindenfeld J; Reddy VY; Hasenfuss G; Kuck KH; Boscardin J; Gibbons R; Burkhoff D;
    J Card Fail; 2015 Jan; 21(1):16-23. PubMed ID: 25285748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac contractility modulation in patients with heart failure - A review of the literature.
    Bazoukis G; Saplaouras A; Efthymiou P; Yiannikourides A; Liu T; Letsas KP; Efremidis M; Lampropoulos K; Xydonas S; Tse G; Armoundas AA
    Heart Fail Rev; 2024 May; 29(3):689-705. PubMed ID: 38393423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
    Butter C; Wellnhofer E; Schlegl M; Winbeck G; Fleck E; Sabbah HN
    J Card Fail; 2007 Mar; 13(2):137-42. PubMed ID: 17395055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
    Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
    J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond.
    Tschöpe C; Kherad B; Klein O; Lipp A; Blaschke F; Gutterman D; Burkhoff D; Hamdani N; Spillmann F; Van Linthout S
    Eur J Heart Fail; 2019 Jan; 21(1):14-22. PubMed ID: 30485591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proportion of Patients Eligible for Cardiac Contractility Modulation: Real-Life Data from a Single-Center Heart Failure Clinic.
    Pilecky D; Muk B; Majoros Z; Vágány D; Kósa K; Szabó M; Szögi E; Dékány M; Kiss RG; Nyolczas N
    Cardiology; 2021; 146(2):195-200. PubMed ID: 33582674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
    Yu CM; Chan JY; Zhang Q; Yip GW; Lam YY; Chan A; Burkhoff D; Lee PW; Fung JW
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1341-9. PubMed ID: 20083066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure.
    Sabbah HN; Haddad W; Mika Y; Nass O; Aviv R; Sharov VG; Maltsev V; Felzen B; Undrovinas AI; Goldstein S; Darvish N; Ben-Haim SA
    Heart Fail Rev; 2001 Jan; 6(1):45-53. PubMed ID: 11248767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Mando R; Goel A; Habash F; Saad M; Ayoub K; Vallurupalli S; Maskoun W
    Cardiovasc Ther; 2019; 2019():9769724. PubMed ID: 31772622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.